Phase 2b Study Explores Efficacy of MM-120 for the Treatment of GAD
Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.
Source: psychiatrictimes.com
Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Designation Today - Breaking & Trending Today
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016
SUZHOU, China, May 22, 2024 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I…
Source: sina.com.hk
V116 Elicits Noninferiority Immune Response Compared with PPSV23 for Pneumococcal Disease
Merck presented results from the STRIDE-10 phase 3 trial at the 34th European Society of Clinical Microbiology and Infectious Diseases in Barcelona, Spain.
Source: pharmacytimes.com
OrthoPediatrics earns breakthrough designation for new scoliosis rod system
OrthoPediatrics earned the FDA's breakthrough designation for the eLLi growing rod system for scoliosis, the devicemaker said May 2.
Source: beckersspine.com
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Source: fool.com